{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:53:40Z","timestamp":1768316020786,"version":"3.49.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"s2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1086\/367563","type":"journal-article","created":{"date-parts":[[2003,4,24]],"date-time":"2003-04-24T01:58:16Z","timestamp":1051149496000},"page":"S84-S90","source":"Crossref","is-referenced-by-count":32,"title":["Body Habitus Changes Related to Lipodystrophy"],"prefix":"10.1093","volume":"36","author":[{"given":"Fred","family":"Sattler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"rf1_239","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00004"},{"key":"rf2_240","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912240-00002"},{"key":"rf3_241","first-page":"13","volume":"736","author":"Reaven GM.","year":"1994","journal-title":"J Intern Med Suppl"},{"key":"rf4_242","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-200012010-00004"},{"key":"rf5_243","doi-asserted-by":"publisher","DOI":"10.1086\/317541"},{"key":"rf6_244","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00042560-200201010-00004","volume":"29","author":"Estrada V","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf7_245","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00204-6"},{"key":"rf8_246","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101260-00024"},{"key":"rf9_247","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04056-3"},{"key":"rf10_248","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101260-00013"},{"key":"rf11_249","doi-asserted-by":"publisher","DOI":"10.1086\/317477"},{"key":"rf12_250","first-page":"59","volume":"5","author":"Galli M","year":"2000","journal-title":"Antivir Ther"},{"key":"rf13_251","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00008"},{"key":"rf14_252","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"rf15_253","unstructured":"Falutz J, Murrahainen N, Workman C, etal Gender is associated with increased body size but not fat depletion in patients with HIV-associated adipose redistribution (HARS) [abstract WePeB4273]. In: Program and abstracts of the 13th International AIDS Conference (Durban, South Africa). 2000; 95."},{"key":"rf16_254","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.6.1932"},{"key":"rf17_255","first-page":"61","volume":"5","author":"Lichtenstein K","year":"2000","journal-title":"Antivir Ther"},{"key":"rf18_256","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199903110-00004"},{"key":"rf19_257","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajcn\/74.5.679","volume":"74","author":"McDermott AY","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"rf20_258","first-page":"59","volume":"5","author":"Galli M","year":"2000","journal-title":"Antivir Ther"},{"key":"rf21_259","unstructured":"Viciana P, Alarcon A, Martin D, etal Partial improvement of lipodystrophy after switching from HIV-1 protease inhibitors (PI) to efavirenz [abstract 48]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). 2000; 84."},{"key":"rf22_260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","volume":"6","author":"John M","year":"2001","journal-title":"Antivir Ther"},{"key":"rf23_261","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","volume":"23","author":"Mulligan K","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf24_262","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200002180-00001"},{"key":"rf25_263","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200007070-00002"},{"key":"rf26_264","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"rf27_265","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109280-00009"},{"key":"rf28_266","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","volume":"30","author":"Cherry CL","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"rf29_267","unstructured":"Viard J, Rakotoambinina B. Lipodystrophic syndromes in a cohort of HIV-1-infected patients receiving HAART with a protease inhibitor [abstract 026]. In: Program and abstracts of the 1st International Workshop on Adverse Drug Reactions and Lipodystropy in HIV (San Diego). 1999; 32-33."},{"key":"rf30_268","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00009"},{"key":"rf31_269","unstructured":"Bernasconi E, Boubaker K, Sudre P, etal Metabolic side effects of antiretroviral therapy in the Swiss Cohort Study [abstract ThOrB703]. In: Programs and abstracts of the 13th International AIDS Conference. 2000; 296."},{"key":"rf32_270","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00005"},{"key":"rf33_271","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, Touraine J. Reversibility of peripheral fat wasting (lipoatrophy) on stopping stavudine therapy [abstract 52]. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections (San Francisco). 2000; 85."},{"key":"rf34_272","unstructured":"Joly V, Flandre P, Meiffredy V, etal Assessment of lipodystrophy in patients previously exposed to AZT, DDI, or DDC, but naive for d4T and protease inhibitors, and randomized between d4T\/3TC\/indinavir and AZT\/3TC\/indinavir (NOVAVIR Trial) [abstract 539]. In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections (Chicago). 2001; 205."},{"key":"rf35_273","unstructured":"Schrooten W, de Mey I, Koitz G, Goebel F, Dreezen C, Colebunders R. Lipodystrophy and antiretroviral treatment [abstract WePeB4268]. In: Program and abstracts of the 13th International AIDS conference (Durban). 2000; 94."},{"key":"rf36_274","unstructured":"Domingo P, Francia E, Torres O, etal Differential effects of zidovudine and stavudine on fat distribution and its associated metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy [abstract ThOrB705]. In: Programs and abstracts of the 13th International AIDS Conference (Durban). 2000; 296."},{"key":"rf37_275","first-page":"55","volume":"5","author":"Bogner J","year":"2000","journal-title":"Antivir Ther"},{"key":"rf38_276","first-page":"76","volume":"5","author":"Amard P","year":"2000","journal-title":"Antivir Ther"},{"key":"rf39_277","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.12.4358"},{"key":"rf40_278","first-page":"50","volume":"4","author":"Jaque S","year":"2002","journal-title":"Clin Exerc Physiol"},{"key":"rf41_279","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604113341504"},{"key":"rf42_280","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.98.5.398","volume":"98","author":"Pyorala M","year":"1998","journal-title":"Circulation"},{"key":"rf43_281","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI119870","volume":"100","author":"Adams M","year":"1997","journal-title":"J Clin Invest"},{"key":"rf44_282","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","volume":"133","author":"Arioglu E","year":"2000","journal-title":"Ann Intern Med"},{"key":"rf45_283","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.2.207"},{"key":"rf46_284","unstructured":"McComsey G, Lonegran T, Fisher R, etal Improvements in lipoatrophy are observed after 24 weeks when stavudine is replaced by either abacavir or zidovudine [abstract 701-T]. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). 2002; 309."},{"key":"rf47_285","unstructured":"John M, James I, McKinnon E, etal A randomized, controlled, open-label study of revision of antiretroviral regimens containing stavudine and\/or a protease inhibitor to zidovudine\/lamivudine\/abacavir to prevent or reverse lipoatrophy: 48 week data [abstract 700-T]. In: Program and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). 2002; 308."},{"key":"rf48_286","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","volume":"125","author":"Schambelan M","year":"1996","journal-title":"Ann Intern Med"},{"key":"rf49_287","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00007"},{"key":"rf50_288","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199910220-00013"},{"key":"rf51_289","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.3.727"},{"key":"rf52_290","unstructured":"Engelson E, Glesby M, Sheikan J, Mendez D, Wang J, Kotler D. Body composition changes during and after growth hormone therapy for lipodystrophy with truncal obesity [abstract ThPpB1437]. In: Program and abstracts of the 13th International AIDS Conference (Durban). 2000; 302."},{"key":"rf53_291","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.8.3480"},{"key":"rf54_292","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.2.942"},{"key":"rf55_293","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.1.239"},{"key":"rf56_294","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199905280-00023"},{"key":"rf57_295","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"rf58_296","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","volume":"133","author":"Ross R","year":"2000","journal-title":"Ann Intern Med"},{"key":"rf59_297","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(91)90239-S"},{"key":"rf60_298","first-page":"331","volume":"10","author":"Krotkiewski M","year":"1986","journal-title":"Int J Obes"},{"key":"rf61_299","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(92)90017-5"},{"key":"rf62_300","doi-asserted-by":"publisher","DOI":"10.1086\/338402"},{"key":"rf63_301","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199902040-00011"},{"key":"rf64_302","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00015"},{"key":"rf65_303","doi-asserted-by":"publisher","DOI":"10.1086\/322680"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/36\/Supplement_2\/S84\/1007312\/36-Supplement_2-S84.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T06:36:27Z","timestamp":1682490987000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/367563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":65,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1086\/367563"],"URL":"https:\/\/doi.org\/10.1086\/367563","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}